Passage Bio, Inc. (PASG) — Financial statements
Income statement, balance sheet, and cash flow for Passage Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.73 | 0.00↓100.0% | 4 | 0.00 | 0.00 | |
| Gross Profit | -0.73 | 0.00↑100.0% | -4 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 23↓42.1% | 40↓32.5% | 60↓30.8% | 86↓26.9% | 118 | |
| General & Administrative Expenses | 20↓20.5% | 25↓39.9% | 42↓15.7% | 49↓17.8% | 60 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 20↓20.5% | 25↓39.9% | 42↓15.7% | 49↓17.8% | 60 | |
| Other Expenses | -0.73↓113.9% | 5↑210.8% | -5↓257.4% | 3↓62.5% | 8 | |
| Operating Expenses | 42↓39.7% | 70↓27.0% | 96↓30.3% | 138↓25.5% | 186 | |
| Total Costs & Expenses | 43↓38.7% | 70↓29.7% | 100↓27.6% | 138↓25.5% | 186 | |
| Operating Results | ||||||
| Operating Income | -43↑38.7% | -70↑29.7% | -100↑27.6% | -138↑25.5% | -186 | |
| Depreciation & Amortization | 0.73↓76.4% | 3↓17.2% | 4↑1.1% | 4↑138.4% | 2 | |
| EBITDA | -42↑31.7% | -62↑36.9% | -98↑25.3% | -132↑25.2% | -176 | |
| EBIT | -43↑33.8% | -65↑36.1% | -102↑24.6% | -135↑23.8% | -178 | |
| Interest & Other Income | ||||||
| Net Interest Income | 2↓46.5% | 4↓23.2% | 6↑146.8% | 2↑561.5% | 0.34 | |
| Interest Income | 2↓46.5% | 4↓23.2% | 6↑146.8% | 2↑561.5% | 0.34 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -5↓371.7% | 2↑164.2% | -3↑62.5% | -8 | |
| Other Income / Expenses | -2↓142.1% | 6↑392.5% | -2↓184.9% | 2↑561.5% | 0.34 | |
| Income Before Tax | -46↑29.7% | -65↑36.5% | -102↑25.0% | -136↑26.6% | -185 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -46↑29.7% | -65↑36.5% | -102↑25.0% | -136↑26.6% | -185 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -46↑29.7% | -65↑36.5% | -102↑25.0% | -136↑26.6% | -185 | |
| Bottom-Line Net Income | -46↑29.7% | -65↑36.5% | -102↑25.0% | -136↑26.6% | -185 | |
| EPS (Basic) | -14.35↑33.1% | -21.44↑42.5% | -37.29↑25.4% | -50.00↑28.1% | -69.51 | |
| EPS (Diluted) | -14.35↑33.1% | -21.44↑42.5% | -37.29↑25.4% | -50.00↑28.1% | -69.51 | |
| Weighted Average Shares | 3↑5.1% | 3↑10.3% | 3↑0.6% | 3↑2.0% | 3 | |
| Weighted Average Diluted Shares | 3↑5.1% | 3↑10.3% | 3↑0.6% | 3↑2.0% | 3 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.